Rodriguez-Calvo, T. ; Chen, Y.C.* ; Verchere, C.B.* ; Haataja, L.* ; Arvan, P.* ; Leete, P.* ; Richardson, S.J.* ; Morgan, N.G.* ; Qian, W.J.* ; Pugliese, A.* ; Atkinson, M.* ; Evans-Molina, C.* ; Sims, E.K.*
Altered β-cell prohormone processing and secretion in type 1 diabetes.
Diabetes 70, 1038-1050 (2021)
Analysis of data from clinical cohorts, and more recently from human pancreatic tissue, indicates that reduced prohormone processing is an early and persistent finding in type 1 diabetes. In this article, we review the current state of knowledge regarding alterations in islet prohormone expression and processing in type 1 diabetes and consider the clinical impact of these findings. Lingering questions, including pathologic etiologies and consequences of altered prohormone expression and secretion in type 1 diabetes, and the natural history of circulating prohormone production in health and disease, are considered. Finally, key next steps required to move forward in this area are outlined, including longitudinal testing of relevant clinical populations, studies that probe the genetics of altered prohormone processing, the need for combined functional and histologic testing of human pancreatic tissues, continued interrogation of the intersection between prohormone processing and autoimmunity, and optimal approaches for analysis. Successful resolution of these questions may offer the potential to use altered prohormone processing as a biomarker to inform therapeutic strategies aimed at personalized intervention during the natural history of type 1 diabetes and as a pathogenic anchor for identification of potential disease-specific endotypes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Typ der Hochschulschrift
Herausgeber
Schlagwörter
C-peptide Ratio; Islet Amyloid Polypeptide; Elevated Proinsulin; 1st-degree Relatives; Healthy Siblings; Insulin; Onset; Expression; Protein; Stress
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
0012-1797
e-ISSN
1939-327X
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 70,
Heft: 5,
Seiten: 1038-1050
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Diabetes Association
Verlagsort
Alexandria, VA.
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502190-001
Förderungen
Canadian Institutes of Health Research
JDRF
Leona M. & Harry B. Helmsley Charitable Trust
National Institute of Diabetes and Digestive and Kidney diseases (NIDDK)
NIDDK
nPOD
Copyright
Erfassungsdatum
2021-06-14